These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19761279)

  • 21. Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™.
    Barrett-Connor E; Wade SW; Downs RW; Ganiats T; Hochberg M; Recker RR; Stolshek BS
    Osteoporos Int; 2015 Aug; 26(8):2175-84. PubMed ID: 25876880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D and bone health in postmenopausal women.
    Malabanan AO; Holick MF
    J Womens Health (Larchmt); 2003 Mar; 12(2):151-6. PubMed ID: 12737713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain.
    Díez A; Carbonell C; Calaf J; Caloto MT; Nocea G
    Menopause; 2012 Jan; 19(1):89-95. PubMed ID: 21934533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ability to follow drug treatment with calcium and vitamin D in postmenopausal women with reduced bone mass.
    de Castro Gomes DA; Valadares AL; Pinto-Neto AM; Morais SS; Costa-Paiva L
    Menopause; 2012 Sep; 19(9):989-94. PubMed ID: 22668820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of adherence to treatment with calcium and vitamin D in the elderly in a basic health area].
    Mateo Pascual C; Julián Viñals R; Castell Alcalá MV; Queipo R; Otero Piume A
    Rev Calid Asist; 2016; 31(1):10-7. PubMed ID: 26476876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
    Kennedy CC; Ioannidis G; Thabane L; Adachi JD; Marr S; Giangregorio LM; Morin SN; Crilly RG; Josse RG; Lohfeld L; Pickard LE; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
    Trials; 2015 May; 16():214. PubMed ID: 25962885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge and compliance from patients with postmenopausal osteoporosis treatment.
    Palacios S; Sánchez-Borrego R; Neyro JL; Quereda F; Vázquez F; Pérez M; Pérez M
    Menopause Int; 2009 Sep; 15(3):113-9. PubMed ID: 19723681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents.
    Gupta G; Aronow WS
    J Am Med Dir Assoc; 2003; 4(4):200-2. PubMed ID: 12837141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland.
    Nurmi-Lüthje I; Sund R; Juntunen M; Lüthje P
    J Bone Miner Res; 2011 Aug; 26(8):1845-53. PubMed ID: 21351147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality.
    Paschalis EP; Gamsjaeger S; Hassler N; Fahrleitner-Pammer A; Dobnig H; Stepan JJ; Pavo I; Eriksen EF; Klaushofer K
    Bone; 2017 Feb; 95():41-46. PubMed ID: 27826025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Bisphosphonates and Calcium plus Vitamin-D Supplements on Cognitive Function in Postmenopausal Osteoporosis§.
    Safer U; Safer VB; Demir SO; Yanikoglu I
    Endocr Metab Immune Disord Drug Targets; 2016; 16(1):56-60. PubMed ID: 27026340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Liu C; Kuang X; Li K; Guo X; Deng Q; Li D
    Food Funct; 2020 Dec; 11(12):10817-10827. PubMed ID: 33237064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
    Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
    Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoporosis among Postmenopausal Women in Jordan: A National Cross-Sectional Study.
    Saadeh R; Jumaa D; Elsalem L; Batieha A; Jaddou H; Khader Y; El-Khateeb M; Ajlouni K; Allouh MZ
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.
    Neuprez A; Bruyère O; Collette J; Reginster JY
    BMC Public Health; 2007 Apr; 7():64. PubMed ID: 17462085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial.
    Hampson G; Martin FC; Moffat K; Vaja S; Sankaralingam S; Cheung J; Blake GM; Fogelman I
    Osteoporos Int; 2003 Sep; 14(9):750-6. PubMed ID: 12904840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study.
    Turbí C; Herrero-Beaumont G; Acebes JC; Torrijos A; Graña J; Miguélez R; Sacristán J; Marín F
    Clin Ther; 2004 Feb; 26(2):245-56. PubMed ID: 15038947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies.
    Ringe JD; Fardellone P; Kruse HP; Amling M; van der Geest SA; Möller G
    Drugs Aging; 2009; 26(3):241-53. PubMed ID: 19358619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.